Healthcare & Life Sciences

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

The Brownie Baker recalls mislabeled muffins with undeclared walnuts, highlighting the life-threatening risks of packaging mistakes in the food industry.

The firm reported a 3.7% drop in net asset value and a net loss for Q1 2026, raising questions about its dividend sustainability despite a stable payout.

The healthcare intelligence giant boosts its buyback program, a move analysts see as a bold bet on its own value and a strategic play in a shifting industry.

The online therapy giant launches a massive giveback, partnering with the WNBA and nonprofits to address the silent mental health crisis facing mothers.

Amid declining Q1 income and NAV, the lender bets on a major healthcare acquisition and a new buyback to bolster shareholder confidence and future growth.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

As insurers invest billions in opaque private loans, state and federal officials are coordinating to manage hidden risks for policyholders and the financial system.

The new alliance combines virtual primary care and health coaching to tackle rising costs, improve employee well-being, and manage GLP-1 medication trends.

With two new studios open and eight more planned, Uni K Wax and franchisee Kami Ebner are betting on Scottsdale's demand for a gentler, cleaner wax.

As a retirement wave looms for nurses, a new local program offers tailored financial planning to a workforce in crisis. Is it enough to help them?

Four rescued sea otters are heading from Vancouver to a new Québec home, a bittersweet move marking a major expansion of Canada's marine conservation efforts.

The healthcare investment bank's new hire signals a major push to dominate the lucrative, complex, and high-stakes world of private equity dealmaking.

A new survey finds most mothers reject the 'routine' label, feeling strong in daily acts. One FemTech firm is now championing a shift from sacrifice to celebration.

UWorld and the Goldwater Foundation award 93 top students, fueling the pipeline of medical researchers poised to tackle society's biggest health challenges.

The acquisition merges point-of-care marketing with digital HCP engagement, creating a powerhouse to reshape how pharma brands connect with doctors and patients.

A five-year exclusive deal for MilliporeSigma to test Genetix's gene therapies is set to ensure safety and expand access to one-time cures for rare diseases.

A new strategic partnership aims to slash preclinical failure rates by integrating advanced AI modeling directly into early-phase drug trials.

After 30 years, Straine consolidates its consulting, analytics, and management arms, a strategic move to clarify its integrated model in a competitive market.

A landmark clinical trial suggests a different form of folate may be better for pregnancy, reducing a controversial byproduct without sacrificing key benefits.